CRMD - CorMedix - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRMD is currently covered by 5 analysts with an average price target of $14. This is a potential upside of $6.49 (61.48%) from yesterday's end of day stock price of $8.67.

CorMedix's activity chart (see below) currently has 56 price targets and 61 ratings on display. The stock rating distribution of CRMD is 93.75% BUY and 6.25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.84% with an average time for these price targets to be met of 286.32 days.

Highest price target for CRMD is $15, Lowest price target is $13, average price target is $14.

Most recent stock forecast was given by from RBC on 28-Apr-2026. First documented stock forecast 12-Dec-2018.

Currently out of the existing stock ratings of CRMD, 15 are a BUY (93.75%), 1 are a HOLD (6.25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Jun-2025

$14

$6.15 (78.34%)

$13

2 months 11 days ago
(28-Apr-2026)

0/5 (0%)

$6.43 (84.94%)

Buy Since 07-Mar-2025

$14

$6.15 (78.34%)

$21

2 months 11 days ago
(28-Apr-2026)

0/3 (0%)

$6.43 (84.94%)

Buy Since 12-Nov-2025

$14

$6.15 (78.34%)

$14

2 months 12 days ago
(27-Apr-2026)

7/13 (53.85%)

$6.18 (79.03%)

92

Buy Since 30-Mar-2022

$15

$7.15 (91.08%)

$16

2 months 12 days ago
(27-Apr-2026)

14/19 (73.68%)

$7.18 (91.82%)

353

Buy Since 25-Mar-2025

$13

$5.15 (65.61%)

$18

5 months 16 days ago
(23-Jan-2026)

0/4 (0%)

$5.73 (78.82%)

Show more analysts

Please expand the browser size to see the chart

What is CRMD (CorMedix) average time for price targets to be met?

On average it took 286.32 days on average for the stock forecasts to be realized with a an average price target met ratio 37.84

Which analyst has the current highest performing score on CRMD (CorMedix) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on CRMD (CorMedix)?

Jason Butler works at JMP and has 5 price targets and 4 ratings on CRMD

Which analyst is the currently most bullish on CRMD (CorMedix)?

Gregory Renza with highest potential upside - $9.15

Which analyst is the currently most reserved on CRMD (CorMedix)?

Jason Butler with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?